Latest gross profit for HUM: $-49B, below the Healthcare sector average of $67B.
Get informed when a big investor buys or sells
+ FollowAs of Jun 30, 2026
Trailing 12 months ending Jun 30, 2026
As of the most recent data (June 2026), HUM shows a gross profit of $-49B. That compares with $87B in the prior-year period — down 156.4% year over year. That is below the Healthcare sector average of $67B. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, HUM's gross profit is now $-49B (was $87B) — a 156.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Humana is outperforming or lagging.
The Healthcare sector average gross profit is about $67B. Humana is at $-49B, which is lower that average. That is roughly 173.5% below the sector mean. Use the comparison chart on this page to see how HUM stacks up against individual peers as well.
Tracking HUM's gross profit over time shows whether Humana is scaling, shrinking, or reshaping that part of the business. The current reading is $-49B That compares with $87B in the prior-year period — down 156.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this gross profit page, Stockcircle has Humana's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect gross profit (currently $-49B) with ownership activity and broader fundamentals.